These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16981554)

  • 1. [Pharmacoeconomic issues in antihypertensive treatment].
    Saito I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():271-5. PubMed ID: 16981554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arterial hypertension: an update].
    Verdecchia P; Angeli F; Mazzotta G; Gentile G; Reboldi G
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):74S-77S. PubMed ID: 20879486
    [No Abstract]   [Full Text] [Related]  

  • 3. [New treatment strategies for the management of hypertension].
    Reinhardt A; Linsel-Nitschke P; Schunkert H
    MMW Fortschr Med; 2009 Nov; 151(46):33-6. PubMed ID: 20043391
    [No Abstract]   [Full Text] [Related]  

  • 4. [Care in hypertension: guidelines and sources of error].
    Simon G
    Orv Hetil; 2005 May; 146(18):849-52. PubMed ID: 15926631
    [No Abstract]   [Full Text] [Related]  

  • 5. The South African Hypertension Guideline 2006 is evidence-based and not cost-effective--a rebuttal.
    Rayner BL; Seedat YK; Milne J; Pinkney-Atkinson V; Veriava Y
    S Afr Med J; 2007 Mar; 97(3):152, 154. PubMed ID: 17440654
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effective therapy for hypertension.
    Barrie W
    West J Med; 1996 Apr; 164(4):303-9. PubMed ID: 8732729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Innovation or pseudo-innovation: that is the question].
    Unger T
    Med Klin (Munich); 2006 Mar; 101(3):257-62. PubMed ID: 16648986
    [No Abstract]   [Full Text] [Related]  

  • 8. Economics of treatment guidelines for hypertension.
    Sheps S; Lenfant C
    J Am Board Fam Pract; 1999; 12(5):421-2. PubMed ID: 10534095
    [No Abstract]   [Full Text] [Related]  

  • 9. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost as a factor in the treatment of hypertension.
    Dart RA
    Contemp Intern Med; 1995 Feb; 7(2):10-4. PubMed ID: 10150334
    [No Abstract]   [Full Text] [Related]  

  • 11. Health economic issues and the future treatment and management of hypertension.
    Giles TD
    AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacoeconomic aspects of the treatment of essential hypertension].
    Martynov AI; Giliarevskiĭ SR; Ostroumova OD; Nesterova MV; Mamaev VI
    Ter Arkh; 2001; 73(9):82-8. PubMed ID: 11642090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
    Ohlsson O
    Lakartidningen; 2004 Dec; 101(49):3984-5. PubMed ID: 15633336
    [No Abstract]   [Full Text] [Related]  

  • 14. The South African Hypertension Guideline 2006 is evidence-based but not cost-effective.
    Gaziano TA
    S Afr Med J; 2006 Nov; 96(11):1170-3. PubMed ID: 17167701
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards a better yardstick: the choice of treatment thresholds in hypertension.
    McAlister FA; Laupacis A
    Can J Cardiol; 1998 Jan; 14(1):47-51. PubMed ID: 9487272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roundtable discussion: Part II--Development of a pharmacoeconomic model in hypertension.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():17-23. PubMed ID: 11183935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical economics of antihypertensive agents].
    Yamazaki T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():285-8. PubMed ID: 16981557
    [No Abstract]   [Full Text] [Related]  

  • 18. Discrepancies between use of antihypertensive drugs and guidelines indications: pharmacoeconomic implications.
    Robbiano L; Martelli A; Brambilla G
    J Hum Hypertens; 2005 Oct; 19(10):819-22. PubMed ID: 15951739
    [No Abstract]   [Full Text] [Related]  

  • 19. [Selection criteria in the treatment of arterial hypertension and recommended guidelines].
    Agabiti-Rosei E; Muiesan ML; Bettoni G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):527-32. PubMed ID: 12497777
    [No Abstract]   [Full Text] [Related]  

  • 20. Considerations in the treatment of mild-to-moderate hypertension.
    Giaquinta D
    Manag Care Interface; 2001 Mar; 14(3):80-1. PubMed ID: 11301960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.